BioTech/Drugs - Redwood City, CA, US
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.
Outlook
Pardot
Salesforce
Route 53
ExactTarget
Amazon AWS
Guardant Health is a leading provider of comprehensive liquid biopsy solutions that are transforming the way cancer is diagnosed and treated. With a focus on precision oncology, Guardant Health's cutting-edge technology and expertise are enabling clinicians to make more informed treatment decisions and improve patient outcomes. At ConnectPlex.ai, we understand the importance of connecting with the right people in the healthcare industry, especially when it comes to innovative companies like Guardant Health. That's why we've created a comprehensive database of company information, including contact details for key personnel at Guardant Health. With our AI-powered lead generation tools, you can easily find and connect with the right people to drive your business forward. Whether you're looking to collaborate, partner, or expand your network, ConnectPlex.ai is the right place to start your search.
Guardant Health is a leading precision oncology company that is dedicated to helping conquer cancer globally. With its proprietary blood tests, vast data sets, and advanced analytics, the company's oncology platform aims to drive commercial adoption, improve patient clinical outcomes, and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched several liquid biopsy-based tests, including Guardant360®, Guardant360 CDx, and GuardantOMNI®, for advanced stage cancer patients, and Guardant Reveal® for early-stage cancer patients. The company's tests fuel the development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection. Guardant Health's cutting-edge technology and commitment to improving cancer care have made it a leader in the BioTech/Drugs industry. With a strong management team and a focus on innovation, the company is poised for continued success in the fight against cancer.
Guardant Health is a company that helps doctors and patients fight cancer. They have special tests that look at blood to figure out the best way to treat cancer. They use a lot of data and fancy math to make sure their tests are accurate. Their goal is to help people beat cancer, make treatment cheaper, and make sure doctors are using the best methods. They have already started using their tests with people who have late-stage cancer, and now they're working on a way to find cancer early in people who don't have any symptoms yet.